Empirical therapy for febrile, neutropenic patients: persistence of susceptibility of gram-negative bacilli to aminoglycoside antibiotics.
Sepkowitz
K A
KA
Brown
A E
AE
Armstrong
D
D
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000517:prevention & control*; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents